Paul O'Connor
St. Michael's Hospital
30 Bond St.
Suite 3-007 Shuter Wing
Toronto
Name/email consistency: high
- Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis. O'Connor, P.W., Goodman, A., Kappos, L., Lublin, F.D., Miller, D.H., Polman, C., Rudick, R.A., Aschenbach, W., Lucas, N. Neurology (2011)
- 250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. O'Connor, P., Filippi, M., Arnason, B., Comi, G., Cook, S., Goodin, D., Hartung, H.P., Jeffery, D., Kappos, L., Boateng, F., Filippov, V., Groth, M., Knappertz, V., Kraus, C., Sandbrink, R., Pohl, C., Bogumil, T., O'Connor, P., Filippi, M., Arnason, B., Cook, S., Goodin, D., Harung, H.P., Kappos, L., Jeffery, D., Comi, G. Lancet. Neurol (2009)
- Oral fingolimod (FTY720) in multiple sclerosis: two-year results of a phase II extension study. O'Connor, P., Comi, G., Montalban, X., Antel, J., Radue, E.W., de Vera, A., Pohlmann, H., Kappos, L. Neurology (2009)
- Efficacy of intramuscular interferon beta-1a in patients with clinically isolated syndrome: analysis of subgroups based on new risk criteria. O'Connor, P., Kinkel, R.P., Kremenchutzky, M. Mult. Scler. (2009)
- Natalizumab and the role of alpha 4-integrin antagonism in the treatment of multiple sclerosis. O'Connor, P. Expert. Opin. Biol. Ther (2007)
- A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses. O'Connor, P.W., Li, D., Freedman, M.S., Bar-Or, A., Rice, G.P., Confavreux, C., Paty, D.W., Stewart, J.A., Scheyer, R. Neurology (2006)
- Relapse rates and enhancing lesions in a phase II trial of natalizumab in multiple sclerosis. O'Connor, P., Miller, D., Riester, K., Yang, M., Panzara, M., Dalton, C., Miszkiel, K., Khan, O., Rice, G., Sheremata, W. Mult. Scler. (2005)
- Randomized multicenter trial of natalizumab in acute MS relapses: clinical and MRI effects. O'Connor, P.W., Goodman, A., Willmer-Hulme, A.J., Libonati, M.A., Metz, L., Murray, R.S., Sheremata, W.A., Vollmer, T.L., Stone, L.A. Neurology (2004)
- The effects of intramuscular interferon beta-Ia in patients at high risk for development of multiple sclerosis: a post hoc analysis of data from CHAMPS. O'Connor, P. Clin. Ther (2003)
- Key issues in the diagnosis and treatment of multiple sclerosis. An overview. O'Connor, P. Neurology (2002)